WBB Securities Upgrades Paratek Pharmaceuticals (PRTK) to Strong Buy
Tweet
Share
E-mailGet Alerts PRTK Hot Sheet
Price: $2.19 -1.79%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 31 | New: 13
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 31 | New: 13
Join SI Premium – FREE
WBB Securities analyst Steve Brozak upgraded Paratek Pharmaceuticals (NASDAQ: PRTK) from Speculative Buy to Strong Buy with a price target of $11.00.
For an analyst ratings summary and ratings history on Paratek Pharmaceuticals click here. For more ratings news on Paratek Pharmaceuticals click here.
Shares of Paratek Pharmaceuticals closed at $3.97 yesterday.
You May Also Be Interested In
- Wells Fargo Upgrades Spotify (SPOT) to Overweight, 'Off Margin Probation'
- Wedbush Upgrades Celsius Holdings (CELH) to Outperform
- CLSA Upgrades Ambuja Cements Ltd. (ACEM:IN) to Underperform (4)
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
